First report of polymyxin B activity in Klebsiella pneumoniae biofilm

J Chemother. 2019 May;31(3):127-131. doi: 10.1080/1120009X.2018.1558751. Epub 2019 Jan 19.

Abstract

Considering the clinical importance of biofilm in medical devices and chronic infections, this study aimed to investigate the action of polymyxin B on Klebsiella pneumoniae (K. pneumoniae) biofilm. The experiments were performed using a biofilm formation assay and the interaction of polysorbate 80 was explored. Both inhibition of biofilm formation and reduction of pre-formed biofilm occurred in a concentration-dependent manner with inhibition as high as 56 and 64%, and reduction of pre-formed biofilm as high as 70 and 66%, with and without polysorbate, respectively. The addition of polysorbate enhances the biofilm reduction, but more studies are needed to elucidate this mechanism. Our findings reveal, for the first time, polymyxin B as a potential agent for the treatment of K. pneumoniae biofilm, a current challenge for clinical practice.

Keywords: Antibacterial; Biofilm; Polymyxin B; Polysorbate 80.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Biofilms / drug effects*
  • Biofilms / growth & development
  • Humans
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Klebsiella pneumoniae / physiology
  • Microbial Sensitivity Tests
  • Polymyxin B / pharmacology*
  • Urine / microbiology*

Substances

  • Anti-Bacterial Agents
  • Polymyxin B